Fig. 4From: Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathwayGLA activates apoptotic signaling pathway through STAT3 pathway. A RPMI-8226 cells were transfected with a STAT3 siRNA for 24Â h followed by GLA treatment for another 24Â h and then the cells were analyzed by flow cytometer. B RPMI-8226 cells were transfected with a STAT3 plasmid for 24Â h, followed by GLA treatment for another 24Â h and cells were then stained with Annexin V-FITC and PI and analyzed by flow cytometer. C RPMI-8226 cells were transfected with a STAT3 siRNA for 24Â h, followed by GLA treatment for another 24Â h. Cells were then subject to western blot assay. D RPMI-8226 cells were transfected with a STAT3 plasmid for 24Â h followed by GLA treatment for another 24Â h. Cells were then applied for western blot assayBack to article page